PainReform announced its Annual General Meeting of Shareholders to be held on September 30, 2024. Key proposals include re-electing Augustine Lawlor and Dr. Ellen S. Baron as external directors for three-year terms, and approving option grants to directors and executives.The company proposes granting 146,318 options to Chairman and Interim CEO Dr. Ehud Geller, and 22,000 options each to other directors. The options have an exercise price of $0.54 per share. Shareholders will also vote on reappointing Kesselman & Kesselman as the independent auditor for 2024.The meeting will be held at the company's attorneys' offices in Bnei Brak, Israel. Shareholders of record as of September 3, 2024 are eligible to vote. Proxy materials are available on PainReform's website.

PainReform announced its Annual General Meeting of Shareholders to be held on September 30, 2024. Key proposals include re-electing Augustine Lawlor and Dr. Ellen S. Baron as external directors for three-year terms, and approving option grants to directors and executives.The company proposes granting 146,318 options to Chairman and Interim CEO Dr. Ehud Geller, and 22,000 options each to other directors. The options have an exercise price of $0.54 per share. Shareholders will also vote on reappointing Kesselman & Kesselman as the independent auditor for 2024.The meeting will be held at the company's attorneys' offices in Bnei Brak, Israel. Shareholders of record as of September 3, 2024 are eligible to vote. Proxy materials are available on PainReform's website.